Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021

SELL
$101.99 - $166.36 $23.2 Million - $37.8 Million
-227,430 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$141.6 - $179.06 $1.17 Million - $1.47 Million
-8,237 Reduced 3.5%
227,430 $37.7 Million
Q1 2021

May 11, 2021

SELL
$132.81 - $182.18 $68.4 Million - $93.9 Million
-515,183 Reduced 68.61%
235,667 $32.9 Million
Q4 2020

Feb 09, 2021

BUY
$138.17 - $184.34 $849,330 - $1.13 Million
6,147 Added 0.83%
750,850 $130 Million
Q3 2020

Nov 12, 2020

BUY
$114.09 - $145.51 $14.4 Million - $18.4 Million
126,162 Added 20.4%
744,703 $104 Million
Q2 2020

Aug 14, 2020

SELL
$89.45 - $129.85 $14 Million - $20.3 Million
-156,475 Reduced 20.19%
618,541 $73.9 Million
Q1 2020

May 14, 2020

BUY
$70.23 - $144.31 $12.7 Million - $26.1 Million
181,064 Added 30.48%
775,016 $77.5 Million
Q4 2019

Feb 14, 2020

SELL
$76.41 - $117.54 $8.74 Million - $13.4 Million
-114,428 Reduced 16.15%
593,952 $69.8 Million
Q3 2019

Nov 14, 2019

BUY
$61.52 - $91.1 $20 Million - $29.6 Million
324,873 Added 84.71%
708,380 $60.9 Million
Q2 2019

Aug 14, 2019

BUY
$58.04 - $66.99 $1.17 Million - $1.35 Million
20,147 Added 5.54%
383,507 $24.9 Million
Q1 2019

May 15, 2019

BUY
$35.52 - $62.62 $12.9 Million - $22.8 Million
363,360 New
363,360 $22.7 Million
Q2 2018

Aug 14, 2018

SELL
$72.38 - $92.5 $24.6 Million - $31.4 Million
-339,651 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$69.46 - $88.57 $2.31 Million - $2.95 Million
33,286 Added 10.86%
339,651 $29.4 Million
Q4 2017

Feb 14, 2018

SELL
$65.94 - $93.31 $1.66 Million - $2.35 Million
-25,200 Reduced 7.6%
306,365 $21.2 Million
Q3 2017

Nov 14, 2017

BUY
$80.87 - $91.08 $9.24 Million - $10.4 Million
114,259 Added 52.58%
331,565 $30.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
217,306
217,306 $16.2 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.